Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Hermansen, Thomas Stig ^a,b   Thomsen, Vibeke Østergaard ^b   Lillebaek, Troels ^b   Ravn, Pernille ^a  

^a HILLERØD HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM DETECTION; CONTROLLED STUDY; DENMARK; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CELATUM; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM MARINUM; MYCOBACTERIUM PEREGRINUM; MYCOBACTERIUM TUBERCULOSIS TEST KIT; MYCOBACTERIUM XENOPEI; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; AGED; ATYPICAL MYCOBACTERIUM; EPIDEMIOLOGY; FACTUAL DATABASE; IMMUNOLOGY; INTERFERON GAMMA RELEASE ASSAY; META ANALYSIS (TOPIC); MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; REGISTER; REPRODUCIBILITY;

ADULT; AGED; DATABASES, FACTUAL; DENMARK; FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; REGISTRIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84899075037     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093986     Document Type: Article

References (40)

1. Falkinham JO 3rd (2002) Nontuberculous mycobacteria in the environment. Clin Chest Med 23: 529-551.
2. von Reyn CF, Waddell RD, Eaton T, Arbeit RD, Maslow JN, et al. (1993) Isolation of mycobacterium avium complex from water in the united states, finland, zaire, and kenya. J Clin Microbiol 31: 3227-3230. (Pubitemid 23335614)
3. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, et al. (2010) Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 182: 970-976.
4. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, et al. (2010) Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: An emerging public health disease. Am J Respir Crit Care Med 182: 977-982.
5. Thomson RM, NTM working group at Queensland TB Control Centre and Queensland Mycobacterial Reference Laboratory (2010) Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis 16: 1576-1583.
6. Marras TK, Chedore P, Ying AM, Jamieson F (2007) Isolation prevalence of pulmonary non-tuberculous mycobacteria in ontario, 1997-2003. Thorax 62: 661-666. (Pubitemid 47235003)
7. Tsai CF, Shiau MY, Chang YH, Wang YL, Huang TL, et al. (2011) Trends of mycobacterial clinical isolates in taiwan. Trans R Soc Trop Med Hyg 105: 148-152.
8. Billinger ME, Olivier KN, Viboud C, de Oca RM, Steiner C, et al. (2009) Nontuberculous mycobacteria-associated lung disease in hospitalized persons, united states, 1998-2005. Emerg Infect Dis 15: 1562-1569.
9. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, et al. (2007) An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367-416.
10. Andrejak C, Thomsen VO, Johansen IS, Riis A, Benfield TL, et al. (2010) Nontuberculous pulmonary mycobacteriosis in denmark: Incidence and prognostic factors. Am J Respir Crit Care Med 181: 514-521.
11. Freeman J, Morris A, Blackmore T, Hammer D, Munroe S, et al. (2007) Incidence of nontuberculous mycobacterial disease in new zealand, 2004. N Z Med J 120: U2580.
12. Huebner RE, Schein MF, Bass JB Jr (1993) The tuberculin skin test. Clin Infect Dis 17: 968-975. (Pubitemid 23358739)
13. van Ingen J, de Zwaan R, Dekhuijzen R, Boeree M, van Soolingen D (2009) Region of difference 1 in nontuberculous mycobacterium species adds a phylogenetic and taxonomical character. J Bacteriol 191: 5865-5867.
14. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, et al. (2011) Interferon-gamma release assays for the diagnosis of latent mycobacterium tuberculosis infection: A systematic review and meta-analysis. Eur Respir J 37: 88-99.
15. Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, et al. (2011) Interferon-gamma release assays for the diagnosis of active tuberculosis: A systematic review and meta-analysis. Eur Respir J 37: 100-111.
16. Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, et al. (2011) Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: A systematic review and meta-analysis. J Acquir Immune Defic Syndr 56: 230-238.
17. Solovic I, Sester M, Gomez-Reino JJ, Rieder HL, Ehlers S, et al. (2010) The risk of tuberculosis related to tumour necrosis factor antagonist therapies: A TBNET consensus statement. Eur Respir J 36: 1185-1206.
18. Ling DI, Zwerling AA, Steingart KR, Pai M (2011) Immune-based diagnostics for TB in children: What is the evidence? Paediatr Respir Rev 12: 9-15.
19. Hoffmann M, Tsinalis D, Vernazza P, Fierz W, Binet I (2010) Assessment of an interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient. Swiss Med Wkly 140: 286-292.
20. Hoffmann M, Ravn P (2010) The use of interferon-gamma release assays in HIV-positive individuals. European Infectious Diseases 4: 23.
21. Leidl L, Mayanja-Kizza H, Sotgiu G, Baseke J, Ernst M, et al. (2010) Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur Respir J 35: 619-626.
22. Vincenti D, Carrara S, Butera O, Bizzoni F, Casetti R, et al. (2007) Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: A pilot study. Clin Exp Immunol 150: 91-98. (Pubitemid 47383295)
23. van Ingen J, Rahim Z, Mulder A, Boeree MJ, Simeone R, et al. (2012) Characterization of mycobacterium orygis as M. tuberculosis complex subspecies. Emerg Infect Dis 18: 653-655.
24. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK (1996) Molecular analysis of genetic differences between mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178: 1274-1282. (Pubitemid 26073382)
25. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P (1996) Evidence for occurrence of the ESAT-6 protein in mycobacterium tuberculosis and virulent mycobacterium bovis and for its absence in mycobacterium bovis BCG. Infect Immun 64: 16-22. (Pubitemid 26009335)
26. Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, et al. (2009) Clinical evaluation of the QuantiFERON-TB gold test in patients with non-tuberculous mycobacterial disease. Int J Tuberc Lung Dis 13: 1422-1426.
27. Riazi S, Zeligs B, Yeager H, Peters SM, Benavides GA, et al. (2012) Rapid diagnosis of mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs). Allergy Asthma Proc 33: 217-226.
28. Lein AD, von Reyn CF, Ravn P, Horsburgh CR Jr, Alexander LN, et al. (1999) Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to mycobacterium avium complex and those with pulmonary disease due to mycobacterium tuberculosis. Clin Diagn Lab Immunol 6: 606-609. (Pubitemid 29330751)
29. Detjen AK, Keil T, Roll S, Hauer B, Mauch H, et al. (2007) Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 45: 322-328. (Pubitemid 47101028)
30. Wang JY, Chou CH, Lee LN, Hsu HL, Jan IS, et al. (2007) Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gamma. Emerg Infect Dis 13: 553-558. (Pubitemid 46525099)
31. Siddiqi UR, Chagan-Yasutan H, Nakajima C, Saitoh H, Ashino Y, et al. (2012) Distinct clinical features in nontuberculous mycobacterial disease with or without latent tuberculosis infection. Tohoku J Exp Med 226: 313-319.
32. Ra SW, Lyu J, Choi CM, Oh YM, Lee SD, et al. (2011) Distinguishing tuberculosis from mycobacterium avium complex disease using an interferon-gamma release assay. Int J Tuberc Lung Dis 15: 635-640.
33. Park SY, Jeon K, Um SW, Kwon OJ, Kang ES, et al. (2009) Clinical utility of the QuantiFERON-TB gold in-tube test for the diagnosis of active pulmonary tuberculosis. Scand J Infect Dis 41: 818-822.
34. Adams LV, Waddell RD, Von Reyn CF (2008) T-SPOT.TB test(R) results in adults with mycobacterium avium complex pulmonary disease. Scand J Infect Dis 40: 196-203. (Pubitemid 351260426)
35. van Leeuwen RM, Bossink AW, Thijsen SF (2007) Exclusion of active mycobacterium tuberculosis complex infection with the T-SPOT.TB assay. Eur Respir J 29: 605-607. (Pubitemid 46372111)
36. Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, et al. (2006) Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Clin Infect Dis 43: 1540-1546. (Pubitemid 44901894)
37. Kuznetcova TI, Sauty A, Herbort CP (2012) Uveitis with occult choroiditis due to mycobacterium kansasii: Limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity). Int Ophthalmol.
38. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR (2012) Prevalence of nontuberculous mycobacterial lung disease in U.S. medicare beneficiaries. Am J Respir Crit Care Med 185: 881-886.
39. Lee SK, Lee EJ, Kim SK, Chang J, Jeong SH, et al. (2012) Changing epidemiology of nontuberculous mycobacterial lung disease in south korea. Scand J Infect Dis 44: 733-738.
40. Hernandez-Garduno E, Rodrigues M, Elwood RK (2009) The incidence of pulmonary non-tuberculous mycobacteria in british columbia, canada. Int J Tuberc Lung Dis 13: 1086-1093.